Omnicell, Inc. Net Common Equity Issued/Repurchased 2010-2024 | OMCL
Omnicell, Inc. net common equity issued/repurchased from 2010 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
| Omnicell, Inc. Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2023 | $23 |
| 2022 | $-12 |
| 2021 | $67 |
| 2020 | $53 |
| 2019 | $41 |
| 2018 | $31 |
| 2017 | $30 |
| 2016 | $18 |
| 2015 | $-33 |
| 2014 | $-2 |
| 2013 | $6 |
| 2012 | $-2 |
| 2011 | $-6 |
| 2010 | $7 |
| 2009 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.840B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||